Stocks across market-cap ranges moved sharply on Tuesday as company announcements, analyst actions and clinical updates drove intraday gains and losses.
The session produced pronounced winners in the technology and semiconductor segments as well as significant volatility among biotech and small-cap issues. Below are the most prominent movers categorized by approximate market-cap bands.
Mega-Cap Movers ($200 billion USD and higher)
- Cisco (CSCO) - Cisco unveils cloud control platform for AI agent management: +5.03%
- Applied Materials (AMAT): +5.18%
- Qualcomm (QCOM): +4.86%
- Alibaba (BABA): +4.8%
- Caterpillar (CAT): +4.52%
- Lam Research (LRCX): +4.35%
- Avago Technologies (AVGO); Broadcom unveils broadband Edge AI portfolio with Wi-Fi 8: +3.35%
- Microsoft (MSFT): -3.88%
- Palantir Technologies (PLTR): -5.14%
- Dell (DELL): -6.3%
Large-Cap Stock Movers ($10-$200 billion USD)
Large-cap technology and related industrial names dominated the list of movers, with several stocks posting double-digit percentage moves.
- Marvell Technology (MRVL): +29.21%
- Coherent (COHR): +17.3%
- Hewlett Packard Enterprise (HPE); HPE appoints Elliott partner to board of directors: +15.66%
- Lumentum Holdings (LITE): +13.17%
- Corning (GLW): +13.24%
- Fabrinet (FN): +11.33%
- New Providence Acquisition Corp N (ASTS): +11.28%
- Bloom Energy (BE): +11.0%
- Semtech (SMTC): +10.79%
- Nu Holdings (NU); BofA downgrades Nu Holdings stock rating on CFO transition concerns: -11.2%
Mid-Cap Stock Movers ($2-$10 billion USD)
Mid-cap moves were influenced by clinical trial results, corporate staffing changes and analyst coverage decisions.
- Legend Biotech (LEGN); Legend Biotech reports phase 1 data for in vivo CAR-T therapy: +39.47%
- Aehr Test Systems (AEHR): +19.92%
- Smart Global Holdings (PENG); Penguin Solutions CFO to step down, reaffirms 2026 outlook: +18.46%
- Octave Intelligence (OCTV); RBC Capital initiates Octave Intelligence stock at Sector Perform: +16.03%
- Camtek (CAMT): +15.64%
- Praxis Precision Medicines (PRAX); Praxis reports phase 2/3 epilepsy trial missed primary endpoint: -16.33%
- Fundrise Innovation Fund (VCX): -16.87%
- Celcuity (CELC); Celcuity’s gedatolisib shows superior results in breast cancer trial: -23.54%
Small-Cap Stock Movers ($300 million-$2 billion USD)
Smaller-cap names posted extreme percentage swings, reflecting the higher volatility typical of the group.
- MVLL: +58.08%
- Swarmer (SWMR): +43.66%
- Julong Holding (JLHL): +28.99%
- LITX: +26.1%
- Omnilit Acquisition (OPTX): +18.5%
- Oatly Group (OTLY): -18.04%
- ASTX NYSE (ASTX): -4.89%
- Oddity Tech (ODD): -32.26%
- Social Capital Hedosophia (SPCE): -37.83%
- Fulcrum Therapeutics (FULC); H.C. Wainwright downgrades Fulcrum stock rating on FDA concerns: -51.32%
The day’s activity underscores the mix of drivers affecting markets: product and technology announcements, corporate governance moves, analyst ratings, and clinical trial updates. Technology and semiconductor names featured prominently among gains, while biotech and some small-cap issues drew sharp downward pressure when trial results or analyst downgrades were reported.
Market participants tracking intraday movers may find the session indicative of how discrete corporate developments can produce outsized percentage moves across market-cap segments.